Skip to main content
Autobound logo
Alaunos Therapeutics, Inc.SEC 8-K

Faces Nasdaq delisting for failing to maintain $2.5M minimum stockholders' equity.

Read at SEC EDGAR

What happened

4 signals in this filing. The company's failure to meet Nasdaq's minimum equity requirement signals severe financial distress and potential insolvency.

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Oct 9, 2026

More SEC 8-K signals at other companies

The full record

From the Signal API record

Numbers

Dollar figureminimum stockholders' equity requirement for Nasdaq listing
$2.5M

Details

CIK
1107421
Accession number
0001193125-26-419154
Timeframe
Immediate
Filing year
2026
Fiscal year end
10/05
Why it matters
Treasury/cash management needs
Signal category
Financial

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Oct 13, 2026
signal_type
sec-8k
signal_subtype
cashFlowConcern

Use this data

Get every SEC 8-K signal for Alaunos Therapeutics, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Alaunos Therapeutics, Inc. this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/63842658-bcd3-4680-a341-7a6a04e95dfe returns this record as JSON. POST /v1/companies/enrich returns every signal for alaunos.com.

{
  "signal_id": "63842658-bcd3-4680-a341-7a6a04e95dfe",
  "signal_type": "sec-8k",
  "signal_subtype": "cashFlowConcern",
  "detected_at": "2026-10-13T07:05:16.077+00:00",
  "company": {
    "name": "Alaunos Therapeutics, Inc.",
    "domain": "alaunos.com"
  },
  "data": {
    "detail": "The company's failure to meet Nasdaq's minimum equity requirement signals severe financial distress and potential insolvency. This pressure to stabilize finances creates an urgent need for cost controls, operational efficiencies, and financial restructuring services.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "minimum stockholders' equity requirement for Nasdaq listing",
      "dollar_millions": 2.5
    },
    "summary": "Faces Nasdaq delisting for failing to maintain $2.5M minimum stockholders' equity.",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1107421/000119312526419154/tcrt-20261005.htm",
    "filing_date": "2026-10-09",
    "filing_year": 2026,
    "fiscal_year_end": "10/05",
    "sales_relevance": "Treasury/cash management needs",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.